Zolpidem and Ayvakit drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zolpidem (zolpidem tartrate) and Ayvakit (avapritinib). Common drug interactions include asthma among females and blood pressure decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Zolpidem and Ayvakit. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Zolpidem?
Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.
What is Ayvakit?
Ayvakit has active ingredients of avapritinib. eHealthMe is studying from 7,362 Ayvakit users. Check the latest studies of Ayvakit.
18 people who take Zolpidem and Ayvakit together, and have interactions are studied.

What are the common drug interactions of Zolpidem and Ayvakit, by gender? *:
female:
- Asthma
- Contusion (a type of hematoma of tissue in which capillaries)
- Depressed mood
- Dyspnoea (difficult or laboured respiration)
- Mobility decreased (ability to move is reduced)
- Anaemia (lack of blood)
- Confusional state
- Face oedema (swelling of face)
- Hypokalaemia (low potassium)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
male:
- Blood pressure decreased
- Dizziness
- Eye discharge
- Post procedural haemorrhage (post procedural bleeding)
- Sinusitis (inflammation of sinus)
- Asthenia (weakness)
- Tryptase increased
- Diarrhoea
- Fatigue (feeling of tiredness)
- Oedema peripheral (superficial swelling)
What are the common drug interactions of Zolpidem and Ayvakit, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
40-49:
- Asthma
- Contusion (a type of hematoma of tissue in which capillaries)
- Depressed mood
- Dyspnoea (difficult or laboured respiration)
- Mobility decreased (ability to move is reduced)
- Hypersensitivity
50-59:
n/a
60+:
- Blood pressure decreased
- Dizziness
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Headache (pain in head)
- Heart rate decreased
- Blood pressure fluctuation
- Hypertension (high blood pressure)
- Anaemia (lack of blood)
- Confusional state
What are the existing conditions these people have? *
- Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 13 people, 72.22%
- High Blood Pressure: 8 people, 44.44%
- Neoplasm Malignant (cancer tumour): 2 people, 11.11%
- Malignant Mast Cell Neoplasm (cancerous tumour of mast cell (immune cell)): 2 people, 11.11%
- Diffuse Cutaneous Mastocytosis (a condition that presents at birth with skin that is thickened and easily blistered): 2 people, 11.11%
- Anaemia (lack of blood): 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Zolpidem and Ayvakit?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zolpidem and Ayvakit:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zolpidem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ayvakit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zolpidem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ayvakit and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on zolpidem tartrate and avapritinib (the active ingredients of Zolpidem and Ayvakit, respectively), and Zolpidem and Ayvakit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Folic Acid cause Musculoskeletal Chest Pain? - a second ago
- Drug interactions of Theo-Dur and Calcipotriene - 7 seconds ago
- Drug interactions of Lorazepam and Trental - 7 seconds ago
- Iron Deficiency Anaemia and Drug Exposure During Pregnancy - 10 seconds ago
- Could Baclofen cause Asthenopia? - 10 seconds ago
- Drug interactions of Eprex and Duragesic-100 - 16 seconds ago
- Drug interactions of Ticlid and Morphine - 22 seconds ago
- Could Hyzaar cause Tricuspid Valve Incompetence? - 22 seconds ago
- Drug interactions of Selegiline Hydrochloride and Zolpidem Tartrate - 27 seconds ago
- Drug interactions of Zetia and Glimepiride - 27 seconds ago